Intestinal Failure Associated Liver Disease clinical trials

Explore recruiting intestinal failure associated liver disease clinical trials.

Recruiting intestinal failure associated liver disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intestinal Failure Associated Liver Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orziloben (NST-6179) in Subjects with Intestinal Failure-Associated Liver Disease (IFALD)

Belgium, Denmark, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Intestinal Failure Associated Liver Disease trials by city

Intestinal Failure Associated Liver Disease in Toronto Intestinal Failure Associated Liver Disease in Vancouver Intestinal Failure Associated Liver Disease in Montreal Intestinal Failure Associated Liver Disease in Calgary Intestinal Failure Associated Liver Disease in Edmonton Intestinal Failure Associated Liver Disease in Ottawa Intestinal Failure Associated Liver Disease in Winnipeg Intestinal Failure Associated Liver Disease in Quebec City Intestinal Failure Associated Liver Disease in Hamilton Intestinal Failure Associated Liver Disease in Kitchener Intestinal Failure Associated Liver Disease in London Intestinal Failure Associated Liver Disease in Halifax Intestinal Failure Associated Liver Disease in New York Intestinal Failure Associated Liver Disease in Los Angeles Intestinal Failure Associated Liver Disease in Chicago Intestinal Failure Associated Liver Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease